Effect of Padzahr Tablet on Biochemical Indices of Bone Remodeling in Postmenopausal Females with Osteopenia: A Randomized Double-Blind Placebo-Controlled Trial
2024

Effect of Padzahr Tablet on Bone Health in Postmenopausal Women

Sample size: 48 publication 10 minutes Evidence: low

Author Information

Author(s): Rafiee Shabnam, Hossein-nezhad Arash, Maghbooli Zhila, Zargaran Arman, Emamgholipour Solaleh, Ghasemi Afsaneh, Ahmadi Mehrnoosh, Esmaeeli Hadi, Karimi Mehrdad

Primary Institution: Tehran University of Medical Sciences

Hypothesis

Does Padzahr improve bone remodeling in postmenopausal women with osteopenia?

Conclusion

The study found that Padzahr treatment did not lead to significant changes in bone turnover markers after three months.

Supporting Evidence

  • The study included 48 postmenopausal women diagnosed with osteopenia.
  • Participants were randomly assigned to receive either Padzahr or a placebo.
  • Blood samples were taken to measure bone turnover markers before and after treatment.
  • Results showed no significant differences in bone turnover markers between the two groups.

Takeaway

The study tested a clay tablet called Padzahr to see if it helps bones in older women, but it didn't make a difference.

Methodology

This was a randomized double-blind placebo-controlled trial with 48 postmenopausal women divided into two groups for 12 weeks.

Potential Biases

There may be risks of bias due to the small sample size and potential participant dropout.

Limitations

The study had a small sample size and a short duration, which may have affected the results.

Participant Demographics

Postmenopausal women aged 45 to 65 with osteopenia.

Statistical Information

P-Value

p>0.05

Statistical Significance

p>0.05

Digital Object Identifier (DOI)

10.31661/gmj.v12i.2950

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication